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1. Introduction  
Intracardiac electrostimulation devices have achieved remarkable progresses in the 
treatment of patients with heart disorders, with an increasing number of implants in recent 
years. One of the most relevant complications are device-related infections that are 
increasing significantly; what is more, the rate of increase in device-related infections per 
year has been disproportionally higher than the rate of newly implanted devices. Such 
infections are caused mainly by staphylococci and are associated with the formation of 
biofilms on the device. Diagnosis requires both a well-defined etiology, with the obtainment 
of appropriate samples, and a well-established location (catheter lead and/or endocardium) 
in order to carry out the most appropriate therapeutic strategy, which usually requires both 
a complete device withdrawal and a correct antibiotic treatment. But there is still no 
consensus about the most appropriate antibiotic pattern, particularly in relation to its 
duration, and the best time to reintroduce a new device. 
2. Epidemiology and incidence 
Pacemaker infections are infrequent but there has been an increase over last years, with an 
older population associated to an increment in morbidity and mortality rates and in financial 
cost. In a retrospective analysis of the National Hospital Discharge Survey database (Voigt et 
al., 2010) from 1996 through 2006, a 57% increment in cardiac device-related infections was 
registered. A population-based study in Olmsted County Minnesota calculated an incidence of 
permanent pacemaker and implantable cardioverter defibrillator infection of 1.9 per 1000 
device-years (95% confidence interval (CI) 1.1-3.1). The incidence of pocket infection was 1.37 
per 1000 device-years (95% CI 0.62 - 3.05) and pocket infection with bacteremia or device-
related endocarditis occurred in 1.14 per 1000 devices-year (95% CI 0.47 - 2.74) (Uslam et al, 
2007). Another prospective multicenter study in France observed an incidence of pacemaker 
related infective endocarditis of 0.39 cases per 1000 devices-year (Duval et al, 2004). 
Nowadays, the estimated average cost of medical and surgical treatment of this kind of 
infections is $25,000 (Daouriche, 2004). Treatment of pacemaker-related infections typically 
requires a two-stage surgical approach, with complete removal of the implanted system 
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followed by insertion of a new one; so major costs are derived from hospitalization, 
diagnostic procedures, intravenous antibiotics and commonly two surgical procedures with 
a new device. 
3. Pathogenesis 
Staphylococci are the mean etiological agents (60-80%) and include Staphylococcus aureus and 
coagulase-negative staphylococci with meticillin-resistant strains in some institutions. Gram 
negative bacilli represent 5-10% of cases and another 10% are negatives cultures (Table 1). 
Rarely fungi or mycobacteria are etiological agents. 
Early infections are acquired by contamination of cutaneous microbiota when pacemaker is 
implanted or generator is revised (Da Costa et al., 1998). When microorganisms adhere to 
device's surface, biofilms are formed (Daouriche, 2001). The biofilm is an extraordinarily 
complex structure formed by a community of microorganisms, involved in a molecular 
matrix. Their training begins with the adhesion of the microorganisms to the surface of the 
biomaterial through nonspecific physicochemical forces and bacterial structures called 
adhesins, which are different depending on the microbial agent involved. The bacterial 
inoculum needed to cause infection is several thousand times lower in the presence of 
prosthetic material. Once the organism is attached to the surface it produces a matrix, which 
in the case of Staphylococcus epidermidis is composed of a gelatinous substance called slime, 
which consists mostly of polysaccharides (polysaccharide intercellular adhesion). 
Subsequently, depending on the interaction between the microorganisms and the host 
defense systems, there will be or not a progression in the formation of a mature biofilm. 
Periodically shedding fragments of the biofilm with the more superficially located 
organisms liberated in the cardiovascular system will result in symptoms (Vila et al., 2008). 
The microorganisms located within biofilms are protected from host defense mechanisms and 
are resistant to the action of antimicrobials. This resistance is determined by different 
mechanisms such as reduced diffusion of drugs, altered growth rate of microorganisms, 
resistance mechanisms expressed in planktonic bacteria, genetic elements transfer and 
biomaterial own action. In these circumstances it is common that the antimicrobial minimum 
inhibitory concentration for the organisms inside the biofilm is thousands times higher than 
for the microorganisms located on the surface (Rodríguez-Martínez & Pascual, 2008). 
If pocket infections persist they may progress by catheter leads to a systemic infection with 
bloodstream and/or endocardium affectation. In other cases, this systemic involvement is 
caused by a different focus bacteremia that colonizes the leads, as can occur in health-care 
related procedures like vascular catheter related bacteremia (Uslan et al., 2009; Chamis et al., 
2001). 
There are many risk factors for pacemaker devices infection. One retrospective study 
observed that long-term corticoid use (OR: 13.9; 95%CI 1.44-20.29) and the presence of more 
than two pacing leads (OR: 5.41; 95%CI: 1.44-20.29) were independent risk factors for 
pacemakers infections; in contrast, antimicrobial prophylaxis prior to implantation was a 
protective one (OR: 0.087; 95%CI: 0.016-0.48) (Sohail et al., 2006). Another prospective 
multicenter study observed that the occurrence of infection was positively correlated with 
fever within 24 hours before the implantation procedure (OR: 5.83; 95%CI, 2.00-16.98), use of 
temporary pacing before the implantation procedure (OR: 2.46; 95%CI: 1.09-5.13) and early 
reinterventions (OR: 15.04; 95%CI: 6.7-33.73); however, implantation of a new system (OR: 
0.46; 95%CI 0.24-0.87) and antibiotic prophylaxis (OR: 0.4; 95%CI: 0.18-0.86) were negatively 
correlated with risk of infection (Klug et al., 2006). 
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Microorganism 
Sohail et al
N=189 
Alarcón et al
N=243 
Catanchin et al 
N=39 
Chua et al 
N=123 
Staphylococcus aureus 29% 20% 60% 24% 
Coagulase-negative staphylococci 42% 42% 32% 68% 
Other Gram positive cocci 4% 3% 4% NR 
Gram negative  bacilli 9% 9% 4% 17% 
Fungal 2% 1% - NR 
Polymicrobial 7% 9% - 13% 
Culture negative 7% 13% 36% NR 
Table 1. Etiology of intracardiac electronic devices infections in clinical series. 
4. Clinical manifestations 
There are local and systemic infections. Local infections affect only generator’s pocket and 
are expressed by local inflammatory symptoms like pain, tenderness, erythema and 
purulent drainage. In another cases exteriorization of the device material could be the only 
manifestation. Some patients with localized pocket infection have bacteremia without lead 
affectation. One study observed that local manifestations at the site of pacemaker 
implantation are associated with infection of the intravascular part of the leads in 79% of 
patients, and no clinical observations or laboratory investigations permitted identification of 
these patients with negative lead cultures (Klug et al., 2004). 
Systemic infections affect the intravascular catheter lead and/or endocardium; they are 
manifested by fever, pulmonary embolism, severe sepsis and metastatic infections (Table 2). In 
many cases, local and systemic symptoms coexist, but there can also exist a systemic infection 
without any local symptomatology; which is more frequent in late infections. Sometimes, the 
diagnosis of recurrent pneumonia is made due to recurrent embolisms from catheter's tip or 
tricuspid vegetations. Since this is a bacteriemic infection, metastatic infections are frequent 
such as septic arthritis, osteomyelitis or endophthalmitis. In a recent international cohort of 
2781 episodes of infective endocarditis, 10% of them were device-related endocarditis 
(Murdoch et al., 2009). When endocarditis is present, it is right-sided with tricuspid valve or  
 
Clinical variable Range % 
Fever 80-100 
Murmur on examination 20-43 
Local findings 45 
Pulmonary embolism 29-33 
Anemia 66 
Leukocytosis 59 
High erythrocyte sedimentation rate 59 
Positive blood cultures 77-95 
Positive swab cultures from generator-pocket 61 
Lead vegetation 85-92 
Valve vegetation 90-100 
Table 2. Clinical features in intracardiac device-related endocarditis in different series 
(N=180) (Sohail et al., 2008; Massoure et al., 2006; Duval et al., 2004; Del Río et al., 2003) 
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mural endocardium affected. Only in exceptional cases mitral and/or aortic valves are 
affected. In left-sided endocarditis systemic embolism, stroke, congestive heart-failure and 
metastatic infections are more frequent and have a more severe prognosis. 
Leukocytosis with neutrophilia, elevation of the C-reactive protein or another acute phase 
reactant are the main altered laboratory parameters. 
5. Diagnosis 
The diagnostic must be microbiological and anatomical. The main procedures are blood 
cultures and culture of exudates of the pocket. Any purulent drainage should be properly 
processed for staining and suitable cultures. Bacteremia is present in many patients with 
systemic infections and sometimes in local infections too, so blood cultures are crucial for 
diagnostic, perhaps previous to any antimicrobial treatment. Bacteremia can be detected 
even in patients without fever. The sonication of extracted device can be a useful method 
that allows the recovering of microorganisms that cannot be isolated by conventional 
methods. Despite this, the results obtained with these methods must be interpreted with 
caution in the appropriate clinical context, because they can have an uncertain clinical 
significance or can be the result of a contamination (Mason et al., 2011; Rohacek et al., 
2010). 
Transesophageal echocardiography is a good diagnostic procedure to detect leads 
involvement because it has a higher sensibility to detect vegetations than transthoracic 
echocardiography. These vegetations are usually located on the distal extreme of the lead, 
and/or the endocardium, generally at the level of the tricuspid valve, but in some patients 
they may also exist in the endocardial wall and the mitral or aortic valves (Victor et al., 
1999). The vegetations may be single or multiple and often easily distinguishable from the 
strands that are filamentous structures attached to the electrodes without clinical relevance 
(Kerut et al., 2007). In other occasions the affectation of the lead adopts an aspect of 
thickening or sleeve (Klug et al., 2007).  In patients with cardiac prosthetic valves, the 
involvement of the same should be ruled out by transesophageal echocardiography, 
especially when the causative agent is S aureus (Habib et al., 2010). 
6. Medical treatment 
Antimicrobial agents are one of the main elements of treatment, along with early and 
complete withdrawal of the device. Antibiotic regimen depends on the location of the 
infection and its severity. In local infections may be sufficient to use oral antibiotics for 
several days, while severe and/or systemic infections, as those with bacteremia or 
endocarditis, require intravenous antibiotics for several weeks. 
In critically ill patients empirical use of these drugs is justified, especially in systemic 
infections, in patients with significant comorbidities and when a high risk of complication 
development exists. In these cases antibiotics associations directed against the main 
organisms should be used. Since Staphylococcus aureus and coagulase-negative Staphylococci 
are the main microorganisms involved and, depending on each institution, the number of 
meticillin-resistant strains may be high, it is recommended the use of glycopeptides such as 
vancomycin or teicoplanin associated with a drug active against gram-negative bacilli, 
which depends on the epidemiology of each institution and include cefazidime, cefepime, 
piperacillin + tazobactam or carbapenems (Mermel et al., 2009). 
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Vancomycin should be used according to current recommendations, which means that there 
should be given an initial loading dose adjusted to patient’s weight in seriously ill patients 
(25-30 mg/Kg) and continue with the following doses adjusted to renal function and serum 
trough levels (15-20 µg/ml) (Ryback et al., 2009). 
The association of aminoglycosides is not well established, since we only have evidence of a 
decrease in bacteremia duration in some cases, but it is also associated with more adverse 
effects, especially nephrotoxicity (Cosgrove et al., 2009). 
Once culture results are obtained, treatment should be adjusted depending on the isolated 
organisms and their antimicrobial susceptibility. Thus, in the case of methicillin-sensitive 
Staphylococcus aureus (MSSA) the drug of choice should be cloxacillin or nafcillin in 
appropriate doses. In methicillin-resistant Staphylococcus aureus (MRSA), drug selection 
depends on the minimum inhibitory concentration (MIC) against vancomycin: strains with 
MIC ≤ 1 µg/ml should continue with vancomycin at appropriate doses, whereas strains 
with MIC ≥ 1 µg/ml require an alternative to vancomycin (Soriano et al., 2008). In these 
cases, the most employed drugs are daptomycin and linezolid. Daptomycin is a lipopeptide 
antibiotic rapidly bactericidal on most of gram-positive cocci, including drug-resistant 
strains; a recent clinical trial demonstrated it is not inferior to antistaphylococal penicillin or 
vancomycin in patients with bacteremia and right-sided endocarditis by MSSA and MRSA, 
using a dose of 6 mg/Kg/day (Fowler et al., 2006). However, some therapeutic failures on 
this drug at low doses advise for the use of greater doses between 8 and 10 mg/Kg/day. 
Linezolid an oxazolidinone antibiotics exhibit bacteriostatic activity against many Gram-
positive cocci and provide the advantage of having a high bioavailability which permits an 
oral administration and do not require dose adjustment for renal insufficiency; although 
prolonged treatment may have more side effects such as myelosuppression or neuropathy. 
For patients allergic to beta-lactam antibiotics glycopeptides are the drugs of choice. There 
are other alternatives as dalbavancin, telavancin, ceftobiprole or trimethoprim-
sufametoxazole but the experience is limited. 
Infections caused by coagulase-negative staphylococci should follow a similar attitude. In 
methicillin-sensitive strains, oxacillin or nafcillin are the drugs of choice; whereas in strains 
resistant to methicillin, use of vancomycin is preferred, although it is still not clear which 
role do new drugs play in these cases. New drugs such as daptomycin or linezolid are of 
great interest due to the activity of some of these drugs in bacterial biofilms, and maybe the 
need for device removal could be avoided in the future, at least in selected cases (Parra et al., 
2010). 
The use of rifampicin is controversial since it has not been proven to increase its clinical 
efficacy and, in turn, it is associated with an increased number of adverse reactions and 
interactions with other drugs such as oral anticoagulants, used regularly in this population. 
On the other hand, there is a theoretical advantage in its use when a more intense action on 
microorganisms located inside the biofilm is required. However, device removal is 
necessary in most cases to eradicate the infection and after its extraction, rifampicin benefits 
do not appear to outweigh risks, so its use is discouraged (Perlroth et al., 2008). 
Directed treatment for gram negative microorganisms depends on the characteristics of each 
center. In general quinolones, cotrimoxazole, amoxicilin + clavulanate or cephalosporins, 
could be useful. However there is a gradual increase in infections caused by multidrug 
resistant pathogens as gram-negative bacilli-producing β-lactamases by different mechanisms, 
so it may be necessary to employ more complex treatments (Table 3). Once again, the complete 
removal of the device facilitates eradication (Rodríguez-Baño et al., 2010). 
www.intechopen.com
 
Aspects of Pacemakers – Functions and Interactions in Cardiac and Non-Cardiac Indications 
 
112 
There is no consensus on the optimal duration of medical treatment. It is possible that in 
infections involving only the generator pocket, several days treatment duration may be 
sufficient. In systemic infections the antimicrobial regimen depends on the type of organism, 
site of infection (pacemaker lead versus endocardium) and the effective withdrawal of the 
infected device. In the published series, the average treatment duration was of 4-6 weeks, 
although in the series of Dumont et al., they describe 8 patients treated during 8.2 ± 5.4 days 
without recurrence (Dumont et al., 2003). Commonly, 2 weeks of parenteral therapy after 
device removal may be enough if there are no septic complications, whereas when there is 
device-related endocarditis or a complicated Staphylococcus aureus bacteremia, it is necessary 
to prolong this treatment for 4 weeks. In patients who can not remove the system 
completely due to their comorbidity and/or technical difficulties, they may require 
prolonged treatment with antibiotics for several months or even a lifetime (chronic 
suppressive therapy); in these cases the objective would be to keep localized the infection in 
the system, avoiding a possible dissemination. This should be exceptional and restricted to 
selected patients, but is expected to increase in coming years (Baddour, 2001; Baddour et al., 
2010). 
 
Microorganism Antibiotic 
Staphylococcus aureus and Coagulase negative 
Staphylococci 
Meticillin sensible 
Cloxacillin or  nafcillin 
Staphylococcus aureus meticillin resistant 
MIC vancomycin > 1 µg/ml 
MIC vancomycin < 1 µg/ml 
 
Daptomycin. Linezolid  
Vancomycin 
Coagulase negative Staphylococii meticilin resistant Vancomycin 
Enterococcus faecalis Penicillin, Ampicillin 
Enterobacter sp, Serratia sp, Citrobacter freundii, 
Morganella sp 
Cefepime,  carbapenems 
Fluorquinolones 
Pseudomonas aeruginosa 
Cefepime, Ceftazidime, aztreonam 
Piperacillin+tazobactam, carbapenems 
(except ertapenem) Fluorquinolones 
Table 3. Directed antimicrobial therapy for systemic infections. Abbreviations: MSSA, 
meticillin-sensible Staphylococcus aureus; MRSA, meticillin-resistant Staphylococcus 
aureus; MIC, minimal inhibitory concentration. 
7. Surgical techniques 
Although randomized trials comparing lead extraction to conservative management are 
lacking, observational studies have clearly demonstrated the role of extraction in case of 
infections of pacemakers; because mortality rates of device-related endocarditis treated only 
with antibiotics are very high, as much as 66% in some series. 
Like in any other surgical procedure, the best way of treating an infectious complication is 
avoiding it with a good prevention, consisting in a strict aseptic manipulation of a patient 
without signs of infection anywhere and employing periprocedural prophylactic antibiotics. 
A standard regimen includes administration of 2 g of cefazolin intravenously one hour 
before the procedure, or vancomycin, 90 to 120 minutes before surgery, if the patient is 
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penicillin allergic or in centers where oxacillin resistance among staphylococci is high 
(Bertaglia et al., 2006). 
Superficial wound infections that do not involve the device do not require extraction and 
can be managed with oral antibiotherapy; but, in general, foreign body infection requires 
removal of the entire system to ensure a complete eradication and to prevent the recurrence 
of infection. When there is a localized pocket infection, there is still controversy with which 
is the best way to approach. The NASPE 2000 guidelines accept a conservative treatment 
consistent in device removal cutting the exposed parts of the leads; an attitude that is 
proving to be unsuccessful and increases the risk of recurrence or spreading of the infection 
and patient’s mortality (Chua et al., 2000). What is more, the recent AHA scientific statement 
and update (Baddour et al., 2010) does not include this approach. 
The first techniques employed for extraction of a transvenous lead were external traction 
with counter weights or open cardiac surgery with inflow occlusion or cardiopulmonary 
bypass. In 1988 Byrd and his colleagues (Smith et al., 1994) incorporated a percutaneous 
technique for lead extraction attempted via the implant vein using locking stylets and 
dilator sheaths or via the femoral vein using snares, retrieval baskets, and sheaths. After this 
introduction, cardiac pacemaker lead extraction techniques have improved and there are 
currently many options to select. 
7.1 Direct traction 
Direct traction techniques consist in lead traction with standard or locking stylets without 
countertraction. Care must be taken not to compromise the integrity of the lead, because this 
difficult the removal and increases the risk of complications or incomplete extraction. To 
avoid this risk, forceful traction is contraindicated and any lead that cannot be freed from 
tissue without distortion or stretching should be extracted with countertraction techniques. 
7.1.1 Simple traction 
Simple traction is the first employed and most basic lead extraction technique. The lead 
exits via the implant vein using standard non-locking stylets and fixation screw retraction 
clips. A modification consists on prolonged graded traction with increasing weights that 
are connected to the proximal end of the lead. Although it can be performed in any case, 
best results are obtained when used with recently implanted leads (less than one or two 
years). 
When removing older leads, excessive traction may result in coil rupture, leaving fragments 
in the cardiovascular system with subsequent thrombotic or infectious complications. 
Unopposed traction can also lead to invagination of the myocardium, myocardial rupture, 
arrhythmia, hypotension or acute severe tricuspid regurgitation secondary to valve leaflet 
avulsion (Farooqi et al., 2010). 
Rosenheck et al. (2002) employed lead rotation during simple traction technique in 89 
patients with 113 lead extractions. Removal was fully completed in 97 (85.8%) leads with a 
6.9% of partial and an 8% of unsuccessful removal rate. The only predictor of successful 
removal was lead age and there was only a small asymptomatic pericardial effusion in one 
patient. 
7.1.2 Locking stylet 
This technique uses a special traction device to assist in the removal of cardiac leads. This 
specialized stylet wire can be inserted through a cardiac lead's conductor lumen once the 
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proximal connector has been removed. The stylet can then be locked into position, firmly 
grasping the distal end of the lead or anywhere along the conductor coil. This technique 
prevents the risk of elongation of the lead body and coil during exertion, ensuring that the 
entire lead is removed. Compared to simple traction, the use of a locking stylet results in 
extraction of greater number of intact leads (Kennergren et al., 2000) and a reduced risk of 
rupture. 
The use of a locking stylet is limited when the conductor is broken or central lumen distorted, 
and has similar complications than simple traction such as myocardial invagination or 
rupture. 
Alt et al. (1996) described the experience gathered between 1990 and 1994 by seven 
European centers regarding a locking stylet for removal of 150 leads. Complete removal was 
possible in 122 cases (81%) and in 18 cases (12%) a partial removal was obtained. Failure to 
remove the lead with the extraction stylet was experienced in 10 cases (7%). There were no 
major complications or deaths. 
7.2 Lead extraction sheaths 
7.2.1 Telescoping sheaths 
The function of telescoping sheaths is to mechanically disrupt the fibrosis and provide a 
passage to remove a lead. The use of a sheath is a two-staged process: counterpressure 
and countertraction (Byrd & Wilkoff, 2000). In the first stage, the sheath is pushed along 
the lead while a similar traction is applied to the locking stylet to avoid a tear through the 
vascular wall. The second stage is initiated when the sheath has been advanced to the lead 
tip-myocardial interface and countertraction is employed. In this stage, traction is placed 
on the lead while countertraction is utilized in the sheath to minimize the risk of 
myocardial invagination or rupture. Care must be taken to maintain the sheath angle in 
parallel with the lead to minimize the risk of vascular lesion. Although counter traction 
prevents invagination of the myocardium, perforation of the myocardium is still possible. 
Major risks associated with this technique involve vascular lesion and myocardial 
perforation. 
Results using conventional sheaths are reported in the U.S. Lead Extraction Database (Smith 
et al., 1994; and Byrd et al., 1999), with a complete removal rate of 86.8% and partial removal 
rate of 7.5%. Major complications occurred in 2.5% (haemopericardium, tamponade, 
haemothorax and one death). 
7.2.2 Electrosurgical sheaths 
The electrosurgical sheath (fig. 1) uses radiofrequency energy, similarly to a surgical 
cautery tool. It consists on two electrodes settled on the beveled tip of a sheath and the 
radiofrequency energy is conducted between the bipolar electrodes. It is used to locally 
dissect the binding tissue that surrounds and anchors transvenous leads. The tapered 
distal end of the sheath can also be used to mechanically disrupt these adhesions, like a 
conventional one; and dislocation of the tip is achieved with countertraction. 
In the Excl trial (Farooqi et al., 2010) 287 leads in 166 patients were extracted with bipolar 
electrosurgical sheaths; 96% of leads were completely removed, 4% partially removed and 
only one lead could not be removed (laser sheath as an adjunct was used in 2% of cases). 
Major complications included three cardiac tamponade, one haemothorax and an 
arteriovenous fistula. 
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Fig. 1. Intraoperative image of a lead extraction with an electrosurgical sheath. 
Compared to laser ablation, electrosurgical sheaths are designed to be more supple so that 
may be easier to maneuver. The radiofrequency energy is confined to less than one fourth of 
the circumference of the sheath allowing a directed and careful dissection of the tissue and 
reducing the chance of vascular damage; but in the other hand this directional control 
reduces the cutting efficacy through the fibrosis (Verma & Wilkoff, 2004). 
7.2.3 Laser ablation 
The Excimer laser sheath consists on a circumferential thin layer of optical fibers that run 
along the sheath and finish at the distal tip producing a ring of laser light in pulses to a 
tissue depth of 100 μm, dissolving the nearest fibrous tissue adherent to leads. Thus, fibrous 
tissue encapsulating the lead body is removed in a controlled manner and occluded 
vasculature can be re-canalised (Farooqi et al., 2010). 
The outer layer of the sheath is made of plastic and acts as a support for maneuvering the 
laser but for mechanical countertraction too. Compared to electrosurgical sheaths, the 
circumferencial cutting is more powerful for extraction of multiple leads or with older 
implantation date, and in veins occluded by clot and fibrosis too. On the other hand, this 
circumferential cutting increases the risk of venous laceration, especially at the superior 
vena cava. 
Appropriate sizing of the laser sheath and a proper traction/countertraction technique are 
crucial to prevent complications. A coaxial orientation of the sheath and lead, with the 
leading edge of the sheath oriented away from the wall of the vessel decreases the risk of 
vascular injury; and we must be careful not to advance the outer sheath more deeply than 
the laser sheath to avoid pinching the vascular wall (Henrikson & Brinker, 2008). 
Major complications associated with laser-assisted lead extraction include: major venous 
injury, arrhythmia, myocardial tear, pneumothorax, hemothorax, arteriovenous fistula, 
tricuspid valve injury and pulmonary embolus (Lawton et al., 2006). 
The total initial experience of laser lead extraction in the U.S. (Byrd et al., 2002) was 
reported on 2561 pacing and defibrillator leads from 1684 patients at 89 sites, with a 
procedural success rate of 90%, a major complication rate (tamponade, hemothorax, 
pulmonary embolism, lead migration, and death) of 1.9% and an in-hospital death rate of 
0.8%. The latest report about laser lead extraction is the LExICon study (Wazni et al., 
2010), an observational retrospective study of 2405 consecutive laser-assisted lead 
extractions in 13 sites in the U.S. and Canada. In this study, the most common indication 
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for extraction was infection and a 96.5% of leads were completely removed, with a 
procedural failure rate that statistically increased when leads were implanted for more 
than 10 years. The clinical success rate was of 97.7% (resolution of clinical goals associated 
with the indication for lead removal), and failure to achieve it was associated with body 
mass index <25 kg/m2 and low extraction volume centers. Major adverse events (any 
complication related to the procedure that required procedural intervention or transfusion 
to prevent death, threat to life, or any complication related to the procedure that resulted 
in death or serious harm to bodily function or structure) occurred in 1.4% of procedures, 
with a death rate of 0.28%; and were associated with body mass index <25 kg/m2. 
Indicators of all-cause in-hospital mortality were pocket infections, device-related 
endocarditis, diabetes and creatinine ≥ 2.0; with an overall in-hospital mortality of 1.86%, 
a higher rate than the one presented by Byrd et al in 2002 and that reflects the complex 
comorbid condition of this patient population, especially device-related endocarditis. In 
this study, the all-cause in-hospital mortality rate for the device-related endocarditis 
population was 4.3%, 1.7% for pocket infection and 0.3% for all noninfected patients, 
proving the seriousness of deep advanced and pocket infections. 
Moon et al. (2002), found three independent predictors of the need for laser-assist during 
lead extractions: prolonged implant duration, nonseptic leads and necessary or 
discretionary versus mandatory indications. 
7.3 Femoral and transjugular extraction techniques 
The preferred via for lead extraction is the same transvenous access by which they were 
implanted, usually subclavian, cephalic or axillary veins. However, when removing broken 
or cut leads with free ends and when the primary approach via the implant vein fails, a 
femoral or transjugular access is the procedure of choice. 
The internal jugular transvenous access was described by Mazetti et al. (2008), and, although 
their experience was based only on 18 patients and 22 leads, they achieved a high success 
rate with very few complications. 
Lead extraction using the femoral vein is called “the inferior approach” and probably it is 
the most versatile approach for lead removal. There are two fundamental snaring 
techniques (Belott, 2007): a direct approach in which, once the lead is grabbed with a snare, 
an attempt is made to remove the lead by traction; and a two-step process, by first pulling 
either the proximal or distal end of the lead into the inferior vena cava and secondly, snaring 
the free end and pulling it for its removal. There are many tools for femoral lead extraction; 
the more advanced one is the Byrd Femoral Work Station (Cook Vascular Inc., Leechburg, 
PA). 
Recently (Fischer et al., 2009), it has been described a simple and safe technique of 
transfemoral lead snaring to assist lead extraction and maintain vascular access in the 
setting of venous occlusion, when the distal lead tip pulls free of the myocardium before an 
extraction sheath is passed beyond the point of venous obstruction. 
Finally, both the transjugular and transfemoral approaches have the same potential 
complications of cardiac or vascular perforations. 
7.4 Surgical lead removal and other techniques 
An open heart surgical approach for lead removal should be limited to two scenarios: 
1. Patients with significant retained hardware after percutaneous removal failure. 
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2. Lead vegetations greater than 2 cm in diameter, because of concern of pulmonary 
embolism with percutaneous procedures. This is not a definitive indication because 
there is some experience in transvenous lead extraction with large vegetations without 
precipitating a pulmonary embolism or, even having evidence of it, neither survival nor 
length of hospital stay has been affected by this complication (Meier-Ewert et al., 2003). 
In some cases, a combined technique is the best treatment option. Removal of the distal end 
of the lead by sternotomy and cardiopulmonary bypass due to the presence of large 
vegetations; and a simultaneous percutaneous procedure for extraction of the proximal end, 
due to severe fibrosis around the lead at the venous system, that precluded its traction from 
the atrium. 
Although the currently recommended treatment for pacemaker infection is complete 
removal, both surgery and percutaneous techniques are complex and of very high risk in 
some patients with many comorbidities, in these cases, less invasive techniques have been 
applied at some centers: 
- Closed irrigation system (Hurst et al., 1986), they treated 19 patients for infected or 
eroded permanent pacemaker pockets with local debridement and insertion of a closed 
irrigation system using a solution of tyloxapol and tobramycin. Successful eradication 
of the infection, without complete replacement of the pacemaker system, was achieved 
in all cases. 
- Placement of an antibiotic-releasing envelope to treat an infected pacemaker pocket: only 
one case report has been described in the literature (Lopez, 2010), with good results. 
- Vacuum-assisted system for pacemaker infection: Satsu & Onoe (2010) describe the 
application of vacuum-assisted therapy for treating four patients with infected 
permanent pacemaker with good results. 
7.5 Selection of percutaneous lead extraction technique in permanent transvenous 
pacemaker infections 
Extraction of recently implanted cardiac rhythm devices (less than one year) is commonly a 
safe and easy procedure which consists in pulse generator removal and direct lead traction. 
However, chronically implanted leads become encapsulated by fibrotic attachments along 
any length of the lead where there is contact with the vein, valve or endocardial structures. 
In these cases, percutaneous lead extraction has become the preferred method to remove 
leads with a rate of success in centers with a high-volume case load of 95-97% and high rates 
of resolution of infection. On the other side, these procedures are associated with 
complications rates between 0 and 11% and involve significant risks such as cardiac 
tamponade, hemothorax, pulmonary embolism, lead migration, pneumonia and death. 
Every of these previous described techniques remain useful and its employment depends on 
the indication and the experience of each center, but there are some recent reviews that may 
be of interest in selecting one or another technique. They are summarized in next table 
(Table 4). Anyway, it is important to emphasize that operator experience is vital in 
determining success as familiarity of a wide array of techniques will increase the likelihood 
of uncomplicated extraction. 
Mathur et al. (2003), made a retrospective analysis of various conventional techniques for 
lead extraction, obtaining good results and a low complication rate. They conclude that the 
only independent predictor associated with successful lead extraction with these techniques 
was a shorter dwell time. Success rates for leads in situ for greater than six years 
considerably decreased in their study. 
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Reference Techniques Results Complications 
Mathur et al 
Retrospective 
analysis 
hospital 
database 
1986-1999 
158 leads extracted in 80 
patients: 
- Simple traction 16.4% 
- Locking stylet 6.1% 
- Telescoping sheath 67.3% 
- Transfemoral approach 
6.1% 
- Thoracotomy 4.8% 
Success at 1st procedure 87.7%
 - Cephalic approach 90% 
 - Transfemoral approach 56%
 - Thoracotomy 75% 
Complete lead removal 86.7%
Lead remnants 7.3% 
Complete lead remaining 
6.1% 
Deaths - 0 
Tamponade - 1 
Stroke - 1 
Pulmonary embolism - 1 
Significant bleeding 12% 
Centella et al 
Retrospective 
analysis of their 
experience 
1989-2006 
314 leads extracted in 187 
patients: 
-Symple traction 44 leads 
-Telescoping sheath 34 
patients 
-Electrosurgical sheath 80 
patients 
Complete extraction 96.8% 
48 patients required a second 
technique for lead remnant 
removal 
Deaths - 1 
Tamponade - 1 
Sepsis – 1 
Pulmonary embolism – 1 
Severe tricuspid 
insufficiency – 1 
Rusanov et al 
Retrospective 
analysis of a 
single operator 
experience 
1993-2008 
Percutaneous techniques 
88.8% 
 - Simple traction 
 - Locking stylet 
 - Telescoping sheath 
Open surgical approach 
11.2% 
 - No CPB 4.2% 
 - CPB 6.3% 
Complete extraction 86.2% 
Partial success (<4cm 
retained) 9.2% 
Failure to extract (>4cm 
retained) 4.6% 
Pneumothorax – 2 
(surgical approach) 
Persistent infection – 1 
(percutaneous) 
Tamponade – 1 (surgical 
approach) 
No procedure-related 
deaths 
Neuzil et al 
Prospective 
randomized 
study 
2.5 years 
161 leads implanted for at 
least 6 months in 120 
patients: 
 - 84 leads extracted with 
radiofrequency sheaths 
 - 77 leads extracted with 
telescoping sheaths 
Radiofrequency extraction: 
 - Complete success 93% 
 - Partial success 7% 
Standard extraction: 
 - Complete success 73% 
 - Partial success 14% 
Pulmonary embolism – 2 
Sepsis – 3 
Blood transfusion 
requirement – 3 
No procedure-related 
deaths 
Wilkoff et al 
Randomized 
trial (PLEXES) 
1995-1996 
301 patients with 465 leads: 
 - laser extraction: 244 leads 
 -  non-laser: 221 leads 
Complete extraction: 
 - laser 94% 
 - non-laser 64% 
Partial extraction: 
 - laser 2.5% 
 - non-laser 1.8% 
Failure: 
 - laser 3.3% 
 - non-laser 34% 
Clinical success: 
 - laser 94.8% 
 - non-laser 95.9% 
Tamponade – 2 (laser) 
Hemothorax – 1 (laser) 
Valve damage – 1 (laser) 
Procedure-related death – 
1 (laser) 
Verma & Wilkoff 
Retrospective 
study 
1998-2001 
450 consecutive lead 
extractions: 
 - 354 laser-assisted 
 - 96 radiofrequency-assisted
Procedure time lower in 
radiofrequency group 
Fluoroscopy time reduced in 
radiofrequency group 
No complications in 
radiofrequency group 
Two deaths in laser group 
Success rates comparables 
in both groups 
Table 4. Contemporary reviews of different transvenous lead extraction techniques. 
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In the same manner, Centella et al. (2007) revised their experience with percutaneous lead 
extraction between 1989-2006, using conventional techniques and electrosurgical sheaths. A 
statistically significant relation is observed between younger patients and major 
complication development, as well as with endocarditis being the indication for lead 
removal. 
Rusanov et al. (2010), describe a single operator experience with percutaneous and open 
surgical techniques for lead removal in 143 endocardial leads. Complete radiographic 
success was achieved for 131 leads with a low rate of major complications. They also 
describe an interesting multistage procedure for patients with purulent wounds: first they 
exteriorize the generator and irrigate and débride the pocket while initiate or continue 
antibiotherapy. In a second stage, when wound cultures are negative, they perform lead 
extraction with a caudal approach. They refer an accelerated wound healing with this 
technique. 
Neuzil et al. (2010) performed a prospective randomized study comparing conventional 
telescoping sheaths lead extraction results with electrosurgical sheaths one. They obtained 
statistically significant differences in success rates between both techniques, in favour of the 
electrosurgical system. They also observed a significant reduction in the time of traction 
with this technique. 
Another prospective randomized study is the PLEXES study (Wilkoff et al., 1999), which 
compares lead extraction results using conventional or laser techniques. Extraction efficacy 
was significantly higher in patients randomized to laser-assisted removal, with shorter 
mean procedure duration. Complication rates were not significantly different between both 
groups, with an incidence in the laser group below 2%. 
Verma & Wilkoff (2004) performed a retrospective review of 450 lead extractions in their 
institution and concluded that electrosurgical sheath appeared to have success rates 
comparable to laser sheath; although there was a selection bias because laser had been 
selected for more challenging lead extraction cases. Based on their experience, they 
recommend the use of radiofrequency sheaths, especially in patients at higher risk of 
complications; and they employ laser techniques as first option for cases requiring 
extraction of multiple leads, defibrillator leads, older implantation date ones and in 
occluded veins. 
Regarding to the removal of infected leads, there are some data suggesting that leads 
associated with systemic sepsis may be easier to extract with little effort (Moon et al., 2002) 
and that infected leads that are difficult to remove and require electrosurgical or laser 
sheaths, are unlikely to be infected at their endocardial tip with some reported data 
suggesting that tip-only retentions at incomplete extractions do not develop recurrence of 
infection and do well without another intervention requirement (Kratz & Toole, 2010). 
Finally, there is a short experience in relation to coronary sinus lead extraction. In many 
cases, this leads are extracted with simple traction but there are some reports of laser sheath 
employment for coronary sinus lead removal. 
8. Conclusion 
According to the increasing use of cardiac implantable electrophysiological devices, 
associated infectious complications are increasing, so that the most common essential 
indication for lead extraction remains infected systems. This can be a life-threatening 
complication associated with significant morbidity and mortality and its management 
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represents a difficult challenge for cardiology, cardiac surgery and infectious diseases 
specialists. 
Although we dispose of a wide range of antibiotics to face pacemaker infections, the 
treatment of choice in device-related infections requires its complete removal. Considering 
that are healthcare-related infections, an increasing number of episodes caused by 
multiresistant microorganism strains is expected, so a better knowledge of the role of new 
antimicrobials is mandatory. We also need to investigate which is the appropriate duration 
of antibiotic therapy as well as the optimal time for a new device implantation. 
Nowadays, there are many surgical tools to remove infected leads with high success rates. 
This sort of techniques must be performed at tertiary referral centers with a high volume 
demand on these procedures and with a cardiac surgeon as the primary operator or aware 
of the procedure at least. With a well-structured team and the availability of different 
surgical lead extraction techniques, the rate of major complications is very low. 
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